Results 11 to 20 of about 26 (21)

Interferon beta for secondary progressive multiple sclerosis. [PDF]

Cochrane Database Syst Rev, 2012
La Mantia L, Vacchi L, Di Pietrantonj C, Ebers G, Rovaris M, Fredrikson S, Filippini G.   +6 more
europepmc   +1 more source

Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. [PDF]

Proc Natl Acad Sci U S A, 2004
Hohlfeld R, Wekerle H.
europepmc   +1 more source

c-Type cytochrome biogenesis can occur via a natural Ccm system lacking CcmH, CcmG, and the heme-binding histidine of CcmE. [PDF]

J Biol Chem, 2010
Goddard AD, Stevens JM, Rao F, Mavridou DA, Chan W, Richardson DJ, Allen JW, Ferguson SJ.   +7 more
europepmc   +1 more source

Targeting the pMHC-TCR Interaction: Molecular Strategies and Therapeutic Potential in Autoimmunity. [PDF]

Int J Mol Sci
Nechaeva AM, Mamedov AE, Ovchinnikova LA, Zakharova MY.   +3 more
europepmc   +1 more source

Machine Learning Potential Analysis of Structural Transition in Cu and Ag Nanoparticles: From Icosahedral to Face-Centered Cubic. [PDF]

J Chem Theory Comput
Yang Y, Han J, Viñes F, Illas F.
europepmc   +1 more source

Safety and efficacy of antigen-specific therapeutic approaches for multiple sclerosis: Systematic review. [PDF]

PLoS One
Öztürk HK, Slanař O, Michaličková D.   +2 more
europepmc   +1 more source

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. [PDF]

Signal Transduct Target Ther
Song Y, Li J, Wu Y.
europepmc   +1 more source

A phase I trial of solubilized DR2:MBP ^84-102 (AG284) in multiple sclerosis

Neurology, 2000
To assess the safety, tolerability, and biologic and clinical activity of a solubilized complex comprised of human leukocyte antigen-DR2 with myelin basic protein84-102 (AG284)in patients with secondary progressive MS.Soluble species-specific major histocompatibility complex myelin basic protein91-103 complexes ameliorate disease in a dose-dependent ...
Donald E. Goodkin, Megan Shulman, J L Winkelhake, Emmanuelle Waubant, P.-B. Andersson, Thomas Stewart, Sarah J. Nelson, Nancy J. Fischbein, Patricia K. Coyle, Elliot M. Frohman, L. D. Jacobs, John S. Holcenberg, M. Lee, Simonetta Mocci   +13 more
openalex   +3 more sources

Preclinical and Pharmacological Studies of AG284, a Soluble HLA‐DR2:Myelin Basic Protein Peptide Complex for the Treatment of Multiple Sclerosis

CNS Drug Reviews, 1998
Edward G. Spack, Nancy Wehner, Jeffrey L. Winkelhake   +2 more
openalex   +2 more sources